| Market Cap | ₹59,234Cr |
| ROE | 37.62% |
| P/E Ratio(TTM) | 39.26 |
| EPS(TTM) | 710.09 |
| P/B Ratio | 14.77 |
| Dividend Yield | 1.70% |
| Industry P/E | 39.81 |
| Book Value | 1887.49 |
| Debt to Equity | 0.05 |
| Face Value | 10 |
| Parent Organisation | Abbott India Limited |
| Managing Director | Mr. Vivek Kamath |
| Founded | 1944 |
| NSE Symbol | ABBOTINDIA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 45.26 | ||
| Pfizer | NA (0.00%) | 27.79 | ||
| Astrazeneca Pharma India | NA (0.00%) | 113.92 | ||
| Sanofi Consumer Healthcare India | NA (0.00%) | 48.71 |